Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmssion programme rural Malawi

被引：10

作者：

Buhendwa, L.

Zachariah, R. ^{[1
]}

Teck, R.

Massaquoi, M.

Kazima, J. ^{[2
]}

Firmenich, P.

Harries, A. D. ^{[3
,4
]}

机构：

[1] Brussels Operat Ctr, Dept Med, Med Sans Frontieres, B-1090 Brussels, Belgium

[2] Minist Hlth & Populat, Thyolo Dist Hlth Serv, Thyolo, Malawi

[3] Minist Hlth, HIV Care & Support, Lilongwe, Malawi

[4] London Sch Hyg & Trop Med, London, England

来源：

TROPICAL DOCTOR | 2008年 / 38卷 / 01期

关键词：

D O I：

10.1258/td.2007.060091

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

This study shows that cabergoline (single oral-dose) is an acceptable, safe and effective drug for suppressing puerperal lactation. It could be of operational benefit not only for artificial feeding, but also for weaning in those that breast-feed within preventive mother-to-child HIV transmission programmes in resource-limited settings.

引用

页码：30 / 32

页数：3

共 7 条

[1]

CABALLEROGORDO A, 1991, J REPROD MED, V36, P717

[2]

Fowler MG, 2002, J ACQ IMMUN DEF SYND, V30, P230, DOI [10.1097/00042560-200206010-00012, 10.1097/01.QAI.0000018364.28828.14]

[3] Breast-feeding and transmission of HIV-1 [J].

John-Stewart, G ;

Mbori-Ngacha, D ;

Ekpini, R ;

Janoff, EN ;

Nkengasong, J ;

Read, JS ;

Van de Perre, P ;

Newell, ML .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (02) :196-202

[4]

*MOH, 2003, NAT GUID PREV MOTH C

[5]

ROLLAND R, 1991, BMJ-BRIT MED J, V302, P1367, DOI 10.1136/bmj.302.6789.1367

[6]

Van de Perre P, 2000, ANN NY ACAD SCI, V918, P122

[7]

*WHO, 2003, HIV INF FEED GUID DE

← 1 →